Search Results - "Thaler, Avner"

A Practice Framework for Genetic Testing in Asymptomatic Relatives of Patients With Creutzfeldt‐Jakob Disease: Experience and Insights From Israel.

Authors: Shir, Dror Bregman, Noa David, Aya Bar et al.

Source: European Journal of Neurology. Jun2026, Vol. 33 Issue 6, p1-9. 9p.

Subjects: Genetic testing, Creutzfeldt-Jakob disease, Genetic counseling, Prion diseases, Neurodegeneration, Genetic disorder diagnosis

Geographic Terms: Israel

Imaging Markers in Genetic Forms of Parkinson's Disease.

Authors: Droby, Amgad Thaler, Avner Mirelman, Anat

Source: Brain Sciences (2076-3425). Aug2023, Vol. 13 Issue 8, p1212. 15p.

Whole brain and deep gray matter structure segmentation: Quantitative comparison between MPRAGE and MP2RAGE sequences.

Authors: Droby, Amgad Thaler, Avner Giladi, Nir et al.

Source: PLoS ONE. 8/6/2021, Vol. 16 Issue 8, p1-14. 14p.

Mutations in GBA and LRRK2 Are Not Associated with Increased Inflammatory Markers.

Authors: Thaler, Avner Omer, Nurit Giladi, Nir et al.

Source: Journal of Parkinson's Disease. 2021, Vol. 11 Issue 3, p1285-1296. 12p.

Validity of the Short Weekly Calendar Planning Activity in patients with Parkinson disease and nonmanifesting LRRK2 and GBA carriers.

Authors: Schejter‐Margalit, Tamara Binyamin, Noam Ben Thaler, Avner et al.

Source: European Journal of Neurology. Aug2024, Vol. 31 Issue 8, p1-10. 10p.

Subjects: Parkinson's disease, Dardarin, Scheduling, Montreal Cognitive Assessment, Cognitive testing

Metabolic syndrome does not influence the phenotype of LRRK2 and GBA related Parkinson's disease.

Authors: Thaler, Avner Shenhar-Tsarfaty, Shani Shaked, Yanay et al.

Source: Scientific Reports. 6/9/2020, Vol. 10 Issue 1, p1-8. 8p.

Amantadine Responsive Methcathinone (Ephedrone) Induced Parkinsonism.

Authors: Thaler, Avner Gurevich, Tanya

Source: Movement Disorders Clinical Practice. Apr2024, Vol. 11 Issue 4, p429-430. 2p.

Intact working memory in non-manifesting LRRK2 carriers -- an fMRI study.

Authors: Thaler, Avner Helmich, Rick C. Or‐Borichev, Ayelet et al.

Source: European Journal of Neuroscience. Jan2016, Vol. 43 Issue 1, p106-112. 7p. 1 Color Photograph, 4 Charts.

Subjects: Parkinson's disease, Mild cognitive impairment, Disease prevalence, Short-term memory, Functional magnetic resonance imaging, Brain imaging, Genetic mutation, Executive function

Biochemical markers for severity and risk in GBA and LRRK2 Parkinson's disease.

Authors: Thaler, Avner Omer, Nurit Giladi, Nir et al.

Source: Journal of Neurology. Apr2021, Vol. 268 Issue 4, p1517-1525. 9p.

Analysis of α-synuclein seed amplification assay in carriers of GBA1 and LRRK2 pathogenic variants.

Authors: Fraser, Kyle B Mirelman, Anat Mabrouk, Omar S et al.

Source: Journal of Parkinson's Disease. Mar2026, Vol. 16 Issue 2, p205-216. 12p.

Survival rates among Parkinson's disease patients who carry mutations in the LRRK2 and GBA genes.

Authors: Thaler, Avner Kozlovski, Tal Gurevich, Tanya et al.

Source: Movement Disorders. Oct2018, Vol. 33 Issue 10, p1656-1660. 5p.

Parkinson's disease phenotype is influenced by the severity of the mutations in the GBA gene.

Authors: Thaler, Avner Bregman, Noa Gurevich, Tanya et al.

Source: Parkinsonism & Related Disorders. Oct2018, Vol. 55, p45-49. 5p.

Levodopa-carbidopa intestinal gel for advanced Parkinson's disease: Impact of LRRK2 and GBA1 mutations.

Authors: Thaler, Avner Anis, Saar Ponger, Penina et al.

Source: Parkinsonism & Related Disorders. Oct2024, Vol. 127, pN.PAG-N.PAG. 1p.

High Genetic Diagnostic Yield for Patients with Rare Movement Disorders at a Single‐Center Neurogenetics Clinic.

Authors: Penn, Dvir Amir, Yam David, Gil Ben et al.

Source: Movement Disorders Clinical Practice. Nov2025, Vol. 12 Issue 11, p1811-1820. 10p.

Two Ethnic Clusters with Huntington Disease in Israel: The Case of Mountain Jews and Karaites.

Authors: Zitser, Jennifer Thaler, avner Inbar, Noit et al.

Source: Neurodegenerative Diseases. Dec2017, Vol. 17 Issue 6, p281-285. 5p.

Mild cognitive impairment among LRRK2 and GBA1 patients with Parkinson's disease.

Authors: Thaler, Avner Livne, Vered Rubinstein, Einat et al.

Source: Parkinsonism & Related Disorders. Jun2024, Vol. 123, pN.PAG-N.PAG. 1p.

A cognitive fMRI study in non-manifesting LRRK2 and GBA carriers.

Authors: Bregman, Noa Thaler, Avner Mirelman, Anat et al.

Source: Brain Structure & Function. Apr2017, Vol. 222 Issue 3, p1207-1218. 12p.

A "dose" effect of mutations in the GBA gene on Parkinson's disease phenotype.

Authors: Thaler, Avner Gurevich, Tanya Bar Shira, Anat et al.

Source: Parkinsonism & Related Disorders. Mar2017, Vol. 36, p47-51. 5p.

Differences in Sex‐Specific Frequency of Glucocerebrosidase Variant Carriers and Familial Parkinsonism.

Authors: Thaler, Avner Mirelman, Anat Alcalay, Roy N.

Source: Movement Disorders. Apr2023, Vol. 38 Issue 4, p713-714. 2p.

Single center experience with medical cannabis in Gilles de la Tourette syndrome.

Authors: Thaler, Avner Arad, Shira Schleider, Lihi Bar-Lev et al.

Source: Parkinsonism & Related Disorders. Apr2019, Vol. 61, p211-213. 3p.